Piramal Pharma Limited (BOM:543635)
India · Delayed Price · Currency is INR 213.55
-2.95 (-1.36%)
At close: Aug 21, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 283.58 billion as of August 21, 2026. Its market cap has increased by 11.35% in one year.
Market Cap
283.58B
Enterprise Value
327.14B
Revenue
92.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
213.55
ChartMarket Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has increased from 226.73B to 283.58B, an increase of 25.07%. That is a compound annual growth rate of 6.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 283.58B | 24.01% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
| Oct 19, 2022 | 226.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 554.53B |
| GlaxoSmithKline Pharmaceuticals | 508.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 291.44B |
| Granules India | 208.57B |
| Caplin Point Laboratories | 192.34B |
| AstraZeneca Pharma India | 187.61B |
| Jubilant Pharmova | 138.37B |